[Advances in haematolymphoid pathology in China over the past ten years: retrospect and prospect]

Z H Zhang1, L C Guo2, W Y Zhang3

  • 1Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.

Insights

Chinese experts have advanced haematolymphoid pathology through extensive research and publications. This progress enhances disease diagnosis, provides global data, and optimizes training systems for pathologists.

Area of Science:

  • Hematology
  • Pathology
  • Oncology

Background:

  • Significant advancements in Chinese haematolymphoid pathology over the last decade.
  • Increased publication of research in domestic and international journals.

Purpose of the Study:

  • To summarize the progress in haematolymphoid pathology in China.
  • To highlight the impact on fundamental research and clinical diagnosis.
  • To underscore the development of training systems and interdisciplinary collaboration.

Main Methods:

  • Analysis of publications in the Chinese Journal of Pathology and other authoritative journals.
  • Review of the optimization of domestic diagnostic and training systems.
  • Assessment of the integration with clinical medicine and pathologist cultivation.

Main Results:

  • Nearly 100 articles published, deepening theoretical research.
  • Improved clinical pathological diagnosis levels and generation of valuable Chinese data.
  • Optimized diagnostic and training systems with enhanced clinical integration.
  • Cultivation of numerous specialized pathologists driving discipline innovation.

Conclusions:

  • Chinese contributions have significantly advanced haematolymphoid pathology research and diagnosis.
  • The developed training and diagnostic systems offer a model for global pathology development.
  • Strengthened integration with clinical medicine fosters innovation in the field.